With its cardiac patch fully developed and FDA pre-submission filed, BioXgen is inviting investors and the public to ...

A spokesperson for Birmingham Children's Hospital said the 3D printed heart would be a big help for them in the run up to the ...

Perioperative cardiac risk management in noncardiac surgery is a multifaceted discipline focused on mitigating cardiovascular complications among patients undergoing procedures unrelated to the heart.

Performing left atrial appendage occlusion (LAAO) in patients undergoing cardiac surgery may be beneficial even in the absence of preexisting atrial fibrillation (AF), a meta-analysis suggests. Though ...

UPMC Williamsport has implemented a specialized cardiac resuscitation training program to improve outcomes for patients ...

SOUTHLAKE, Texas, April 24, 2025 /PRNewswire/ -- Renibus Therapeutics ® ("Renibus"), a clinical late-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and ...

Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

High-flow nasal oxygen therapy showed no benefit after cardiac surgery in a major trial. Learn more about the study.

A YEAR AGO, amid media reports questioning the quality and safety of our cardiac surgery program, I asked the Board of Trustees of Catholic Medical Center (CMC) to conduct a comprehensive ...

High-flow nasal oxygen therapy didn't improve survival while maintaining functional indepe ...

Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, ...